Showing results (1911-1920 of 6,713) with videos related to

Sort By:
Pageof 672
Oncotargets and Therapy|June 19, 2018
A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinomaHui Xie, Shengtao Tian, Haipeng Yu, et al.
Oncotargets and Therapy|June 19, 2018
Association of VDR gene TaqI polymorphism with the susceptibility to prostate cancer in Asian population evaluated by an updated systematic meta-analysisLiangliang Chen, Junjun Wei, Shuwei Zhang, et al.
Oncotargets and Therapy|August 30, 2018
Long non-coding RNA NAP1L6 promotes tumor progression and predicts poor prognosis in prostate cancer by targeting Inhibin-β AYuxiao Zheng, Yiren Gao, Xiao Li, et al.
Oncotargets and Therapy|October 1, 2019
Circular RNA SMARCA5 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by miR-19b-3p/HOXA9 axisYaqiu Wang, Huiping Li, Hong Lu, et al.
Oncotargets and Therapy|October 1, 2019
Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort studyJiakun Li, Yaochuan Guo, Shi Qiu, et al.
Oncotargets and Therapy|October 1, 2019
Irisin functions to inhibit malignant growth of human pancreatic cancer cells via downregulation of the PI3K/AKT signaling pathwayDeguo Zhang, Ping Zhang, Luan Li, et al.
Oncotargets and Therapy|October 1, 2019
Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatmentHao Wang, Sha Zhao, Xiaoshen Zhang, et al.
Oncotargets and Therapy|October 1, 2019
Long noncoding RNA ZEB2-AS1 facilitates laryngeal squamous cell carcinoma progression by miR-6840-3p/PLXNB1 axisQiushi Xu, Hongyu Liu, Bing Yu, et al.
Oncotargets and Therapy|October 2, 2019
Positive feedback loop of lncRNA HOXC-AS2/miR-876-5p/ZEB1 to regulate EMT in gliomaNan Dong, Junxiu Guo, Song Han, et al.
Oncotargets and Therapy|October 2, 2019
Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathwayNi Shi, Hao Yu, Tong Chen
Pageof 672